Lucas Nivon
Lucas Nivon is Co-Founder and Executive Committee Member at OpenFold, Venture Partner at Argonautic Ventures, and CEO and Co-Founder at Cyrus Biotechnology. He was a Translational Investigator at the University of Washington and Co-Founder at PedalAnywhere.
Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government
A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.
Cyrus Biotechnology raises $18M and acquires Orthogonal Biologics, adding COVID-19 decoy therapeutic and deep mutational scanning platform
Seattle protein engineering company Cyrus Biotechnology raised $18 million and acquired Orthogonal Biologics, adding a deep mutational scanning platform and two protein therapeutics including a potential COVID-19 decoy. Cyrus leverages University of Washington IPD tools (Rosetta, RoseTTAfold) and has partnerships including a deal with Selecta Biosciences worth up to $1.5 billion.
Cyrus Biotechnology signs protein-engineering deal with Selecta Biosciences worth up to $1.5 billion to develop IL-2/ImmTOR immune therapy
Seattle-based Cyrus Biotechnology struck a protein-engineering collaboration with Boston’s Selecta Biosciences to engineer IL-2 combined with Selecta’s ImmTOR, a deal that could pay Cyrus up to $1.5 billion if milestones are met. Cyrus will use its software and lab testing to enhance IL-2 stability and function, adding to its existing partnerships and commercial sales of Cyrus Bench.
Organizations
See all 7-
Cyrus Biotechnology Executive Officer, Director 2026–present, Co-Founder and Chief Executive Officer 2014–present, Chief Executive Officer · current
-
OpenFold Co-Founder and Executive Committee Member 2022–present · current
-
Argonautic Ventures Venture Partner 2022–present · current
Education
-
Harvard University PhD, Biophysics · 2002–2008
-
Harvard University AB, Biochemistry · 1997–2001
-
Hunter College High School
Online
Questions about Lucas Nivon
Who is Lucas Nivon?
Lucas Nivon is co-founder and chief executive officer at Cyrus Biotechnology, a role Lucas has held since 2014. Lucas was a translational investigator at University of Washington from 2014 to 2015 and co-founder at PedalAnywhere from 2012 to 2015.
What has Lucas Nivon been in the news for?
GeekWire reported in December 2021 that Cyrus Biotechnology acquired Orthogonal Biologics, adding a COVID-19 decoy therapeutic and a deep mutational scanning platform. GeekWire reported in September 2021 that Cyrus Biotechnology signed a protein-engineering deal with Selecta Biosciences to develop an IL-2/ImmTOR immune therapy.
Which organizations is Lucas Nivon associated with?
Lucas Nivon is associated with 7 organizations, including Cyrus Biotechnology as co-founder and chief executive officer since 2014, OpenFold as co-founder and executive committee member since 2022, and Argonautic Ventures as venture partner since 2022. Lucas also held roles at University of Washington, PedalAnywhere, Harvard University and ETH Zurich.
Where did Lucas Nivon study?
Lucas Nivon studied at Harvard University, earning a PhD in Biophysics from 2002 to 2008 and an AB in Biochemistry from 1997 to 2001. Lucas also attended Hunter College High School.
Where is Lucas Nivon based?
Lucas Nivon is based in Seattle, Washington, United States.
Where can I find Lucas Nivon online?
Lucas Nivon is on LinkedIn.